IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 116 filers reported holding IVERIC BIO INC in Q1 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,811,884 | +207.5% | 223,993 | +90.1% | 0.01% | +200.0% |
| Q1 2023 | $2,866,074 | +26.8% | 117,800 | +11.6% | 0.00% | +50.0% |
| Q4 2022 | $2,260,104 | +54.7% | 105,563 | +29.6% | 0.00% | 0.0% |
| Q3 2022 | $1,461,000 | +106.9% | 81,465 | +11.1% | 0.00% | +100.0% |
| Q2 2022 | $706,000 | -31.1% | 73,355 | +20.6% | 0.00% | 0.0% |
| Q1 2022 | $1,024,000 | +10.5% | 60,841 | +9.7% | 0.00% | – |
| Q4 2021 | $927,000 | +35.7% | 55,443 | +31.9% | 0.00% | – |
| Q3 2021 | $683,000 | +271.2% | 42,029 | +43.7% | 0.00% | – |
| Q2 2021 | $184,000 | -51.5% | 29,251 | -52.2% | 0.00% | – |
| Q1 2021 | $379,000 | -55.6% | 61,155 | -50.5% | 0.00% | – |
| Q4 2020 | $854,000 | +669.4% | 123,574 | +281.8% | 0.00% | – |
| Q1 2020 | $111,000 | -86.0% | 32,363 | -65.0% | 0.00% | -100.0% |
| Q4 2019 | $794,000 | – | 92,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
| Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
| Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
| Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
| Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
| Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
| Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
| Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
| FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |